DR Congo's malaria programme (PNLP) uses Fio's 'Deki Reader' devices, applying computer-vision analysis to read malaria rapid diagnostic tests; a peer-reviewed 2022 evaluation across 144 facilities in 3 provinces found workers had over-reported positives vs. the AI-read result.
144
Health facilities included in the 2022 evaluation (Jan-Dec 2022)
185
Healthcare providers trained on Deki Reader use (Jan-Dec 2022)
Deki Reader devices non-operational by study end (Jan-Dec 2022)
300
Deki Reader units deployed at initial scale-up (2015-2016)
Details
Maturity
Scaling
Promoter
Programme National de Lutte contre le Paludisme (PNLP), DRC Ministry of Health, with Chemonics International and Fio Corporation
Period
2015–2016 initial rollout; formally evaluated Jan–Dec 2022 across 144 facilities
Keywords
public health, computer vision, diagnostics, health service delivery
Context
The Democratic Republic of Congo's Ministry of Health, through its Programme National de Lutte contre le Paludisme (PNLP), deployed Deki Reader devices developed by Fio Corporation and rolled out with support from Chemonics International, using computer-vision image-analysis software to automatically interpret malaria rapid diagnostic test strips instead of relying on a health worker's visual reading.
Activities
Results are transmitted to a cloud database (Fionet) that feeds into the national health information system; devices were first deployed at scale, around 300 units, in Haut-Katanga and Lualaba provinces starting in 2015-2016, and a peer-reviewed process evaluation trained 185 healthcare providers on their use across 144 health facilities in Haut-Katanga, Lualaba and Kasai-Central provinces between January and December 2022.
Results
By the end of the 2022 evaluation period, 120 of the deployed devices (83.3%) had functioned for more than ten months while 24 devices (16.7%) were non-operational; the evaluation also found that health workers had systematically over-reported malaria positivity compared with the AI-read result from the same test strip, though the authors stated that a quantified comparison of the two reporting methods would be presented in a separate publication.
Conclusions
The evidence base is comparatively strong for a device-level health intervention, combining a peer-reviewed academic process evaluation with a defined facility count and study period and corroborating vendor and partner documentation, but the peer-reviewed evaluation reports device uptime and implementation feasibility rather than validated diagnostic-accuracy figures, and no evidence was found of a repeated, ongoing, published evaluation cycle since 2022.
Implementation
Indicative cost
Medium (€50k–€500k) — No specific budget figure was found; the medium cost band reflects hardware (Deki Reader devices), cloud data infrastructure (Fionet) and training scaled across 144 facilities and three provinces.
Time to results
Long (> 3 years) — Deployed at scale from 2015-2016 and still active through the January-December 2022 evaluation period, a multi-year long timeline band.
Staffing & skills
Programme National de Lutte contre le Paludisme (PNLP), DRC Ministry of Health, Chemonics International (implementation partner), Fio Corporation (device vendor), 185 trained healthcare providers across 144 facilities
Conditions for success
reliable connectivity to transmit results via Fionet to the national health information system.
sustained device maintenance, given that 16.7% of devices were non-operational by the end of the 2022 evaluation.
training and supervision of health-facility staff on correct RDT strip handling and device use.
Common failure modes
device non-operability over time, with 16.7% of units non-operational within the 2022 study period.
Do you run this practice?
Claim it —
verified implementers get a public contact pathway and can propose corrections.
Data sources
Where this practice's information was retrieved from, and when.